Cell No. : Cell Name
RCB1469 : PLC-γ2^(-) DT40
update : 2024/11/13
|
Comment | PLC-γ2 deficient DT40 cells |
Comment from the depositor | |
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Kurosaki, Tomohiro
|
Originator |
Kurosaki, Tomohiro
|
Year of deposit |
1998
|
Another name |
P10-14
|
Original cell |
DT40
|
Animal |
_avian
< Birds
|
Tissue |
B cell
|
Classification |
mutant
|
Recombinant |
recombinant
|
|
Lifespan |
infinite
|
Morphology |
lymphocyte-like
|
Cellosaurus(Expasy) |
CVCL_1T47
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
Culture method |
|
浮遊細胞の培養に関する一般的な注意(Japanese)
|
Culture medium |
|
RPMI1640 (4mM Glutamine) + 10% FBS + 1% Chicken serum + 50μM 2-Mercaptoethanol
|
Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage cell No |
|
1.5-2 x 10 5 cells/ml
|
Passage ratio |
|
1 : 20 split
|
SC frequency |
|
Subculture : every 2 days
|
Temperature |
|
39.5
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
90% FBS + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Acholeplasma |
|
(-)
|
Animal PCR |
|
OK
|
Others |
|
Freezing : 1.0-1.5x10 7 cells/ml/vial. Thawing : 1ml of cells into 20ml media. It is unnecessary to remove DMSO. Pass the next day.
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
3
|
User's Publication |
4
|
Reference |
2337
Hashimoto A, Okada H, Jiang A, Kurosaki M, Greenberg S, Clark EA, Kurosaki T.
Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor.
J Exp Med
1998
188(7):1287-95
PubMed ID: 9763608
DOI: 10.1084/jem.188.7.1287
|
2281
Sugawara H, Kurosaki M, Takata M, Kurosaki T.
Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor.
EMBO J
1997
16(11):3078-88
PubMed ID: 9214625
DOI: 10.1093/emboj/16.11.3078
|
2283
Takata M, Homma Y, Kurosaki T.
Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis.
J Exp Med
1995
182(4):907-14
PubMed ID: 7561693
DOI: 10.1084/jem.182.4.907
|
User's Publication |
7115
Zaldua N, Llavero F, Artaso A, Galvez P, Lacerda HM, Parada LA, Zugaza JL.
Rac1/p21-activated kinase pathway controls retinoblastoma protein phosphorylation and E2F transcription factor activation in B lymphocytes.
FEBS J.
2016
283:647-61
PubMed ID: 26663827
DOI: 10.1111/febs.13617
|
15039
Walliser C, Tron K, Clauss K, Gutman O, Kobitski AY, Retlich M, Schade A, Röcker C, Henis YI, Nienhaus GU, Gierschik P.
Rac-mediated Stimulation of Phospholipase Cγ2 Amplifies B Cell Receptor-induced Calcium Signaling
J Biol Chem
2015
290(28):17056-72
PubMed ID: 25903139
DOI: 10.1074/jbc.M115.645739
|
18613
de Gorter DJ, Vos JC, Pals ST, Spaargaren M.
The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral
J Immunol
2007
178(3):1405-14
PubMed ID: 17237388
DOI: 10.4049/jimmunol.178.3.1405
|
17351
Blois JT, Mataraza JM, Mecklenbraüker I, Tarakhovsky A, Chiles TC.
B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta
J Biol Chem
2004
279(29):30123-32
PubMed ID: 15138267
DOI: 10.1074/jbc.M402793200
|